Voyager Therapeutics Inc(VYGR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VYGR Voyager Therapeutics Inc

交易中 09-03 15:37:19 EDT

3.38

-0.16

-4.66%

最高3.54	最低3.36	成交量43.41万
今开3.54	昨收3.54	日振幅5.23%
总市值2.08亿	流通市值1.50亿	总股本6,162万
成交额147.58万	换手率0.98%	流通股本4,440万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VYGR","market":"US","secType":"STK","nameCN":"Voyager Therapeutics Inc","latestPrice":3.375,"timestamp":1788464235048,"preClose":3.54,"halted":0,"volume":434079,"delay":0,"changeRate":-0.04661016949152543,"floatShares":44403300,"shares":61617948,"eps":-1.812103,"marketStatus":"交易中","change":-0.165,"latestTime":"09-03 15:37:19 EDT","open":3.54,"high":3.54,"low":3.355,"amount":1475807.4816768,"amplitude":0.05226,"askPrice":3.38,"askSize":780,"bidPrice":3.37,"bidSize":350,"shortable":3,"etf":0,"ttmEps":-1.812103,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788465600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1447218000000,"exchange":"NASDAQ","adjPreClose":3.54,"postHourTrading":{"tag":"盘后","latestPrice":3.57,"preClose":3.54,"latestTime":"19:49 EDT","volume":19112,"amount":67659.46,"timestamp":1788392972819,"change":0.03,"changeRate":0.008475,"amplitude":0.008475},"volumeRatio":1.17298,"impliedVol":1.2687,"impliedVolPercentile":0.4008},"requestUrl":"/m/hq/s/VYGR","defaultTab":"news","newsList":[{"id":"1167839265","title":"Voyager Therapeutics单次静脉注射Vy1706耐受性良好，6个月GLP毒理学研究显示Tau蛋白减少；阿尔茨海默病临床试验预计2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167839265","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167839265?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:02","pubTimestamp":1783944156,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics公司宣布，其候选药物Vy1706在为期六个月的GLP毒理学研究中，单次静脉注射剂量表现出良好的耐受性，并成功降低了Tau蛋白水平。这一积极结果为该药物后续的临床开发奠定了重要基础。公司计划于2026年下半年启动针对阿尔茨海默病的临床试验。随着全球阿尔茨海默病患者群体持续扩大，市场对创新疗法需求迫切。公司预计在2026年下半年正式启动相关临床试验，进一步评估Vy1706在患者中的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148897337","title":"Voyager Therapeutics 将启动Vy1706针对早期阿尔茨海默病成人患者的临床试验；预计2026年下半年开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1148897337","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148897337?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:04","pubTimestamp":1780315496,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics宣布，将启动其候选药物Vy1706针对早期阿尔茨海默病成人患者的临床试验。公司预计，患者给药阶段将于2026年下半年开始。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150375091","title":"Voyager Therapeutics 获 FDA 批准 Vy1706 新药临床试验，开创阿尔茨海默病基因疗法新路径，旨在减少大脑 Tau 蛋白生成","url":"https://stock-news.laohu8.com/highlight/detail?id=1150375091","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150375091?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:02","pubTimestamp":1780315371,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics Inc 宣布，其创新基因疗法 Vy1706 已获得美国食品药品监督管理局（FDA）的新药临床试验（IND）批准。该疗法旨在通过降低大脑中 Tau 蛋白的生成来治疗阿尔茨海默病，标志着首款针对此病理机制的基因治疗策略进入临床开发阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYGR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118784115","title":"Voyager ASGCT最新突破：单次静脉注射Vy1706耐受性良好，三月GLP毒理数据显示Tau蛋白降低；阿尔茨海默病临床试验预计2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1118784115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118784115?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:02","pubTimestamp":1778666559,"startTime":"0","endTime":"0","summary":"在近期举行的美国基因与细胞治疗学会（ASGCT）年会上，Voyager Therapeutics公司公布了一项引人注目的最新研究数据。结果显示，其研究性疗法Vy1706在单次静脉注射后表现出良好的耐受性。更关键的是，为期三个月的良好实验室规范（GLP）毒理学研究数据表明，该疗法能够有效降低与阿尔茨海默病密切相关的Tau蛋白水平。\n基于这些积极的临床前发现，公司计划进一步推进Vy1706的开发进程。针对阿尔茨海默病的首次人体临床试验，目前预计将于2026年下半年正式启动。这一进展标志着Voyager在神经退行性疾病治疗领域的探索迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYGR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138975211","title":"ETF日报｜2倍做多Applied Optoelectronics ETF涨超40%；美国原油ETF涨超11%；商品与能源走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1138975211","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138975211?lang=zh_cn&edition=full","pubTime":"2026-04-03 11:05","pubTimestamp":1775185500,"startTime":"0","endTime":"0","summary":"$2倍做多ASTS ETF-Tradr$上涨20.73%。美股ETF跌幅Top5$Defiance Daily Target 2X Short ASTS ETF$下跌21.24%。该产品两倍做多加密货币索拉纳价格，因索拉纳币价走低，杠杆放大使当日跌幅扩大。大盘指数ETF涨幅Top 5$罗素2000指数三倍做多ETF-Direxion$上涨1.93%。大宗商品ETF涨幅Top 5$美国原油ETF$上涨11.15%。$不动产指数ETF-iShares$上涨1.59%。债券ETF涨幅Top 5$First Trust SSI Strategic Convertible Securities ETF$上涨1.10%。$iShares Convertible Bond ETF$上涨1.04%。$SPDR Portfolio Long Term Corporate Bond ETF$上涨0.72%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLU","CWB","TNA","DRN","FCVT","FXP","IYZ","VOYX","URE","VYGR","AAOX","IWO","DZZ","SOLT","DBC","GLL","ENPH","ASTX","VTWO","ICVT","ICF","LUNR","NBIZ","VCLT","LUNL","ASTS","AAOI","USO","SLON","ENPX","SPLB","UCO","NBIS","UWM","ASTN","PL","ZSL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1193263654","title":"ETF日报｜2倍做多Red Cat ETF涨超28%；二倍做空彭博原油指数ETF涨超10%；小盘与科技走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1193263654","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193263654?lang=zh_cn&edition=full","pubTime":"2026-03-24 10:40","pubTimestamp":1774320000,"startTime":"0","endTime":"0","summary":"Arete Research首次对Hut 8进行覆盖，给予买入评级，并将目标价设定为136美元。$2倍做多VOYG ETF-Tradr$上涨17.42%。$2倍做空PLTR ETF-Defiance$下跌13.31%。大盘指数ETF涨幅Top 5$三倍做多MSCI新兴市场ETF-Direxion$上涨8.93%。该产品三倍做多罗素2000指数，小盘股集体走高推动基金上涨，杠杆属性增强弹性。大宗商品ETF涨幅Top 5$二倍做空彭博原油指数ETF$上涨10.47%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","TNA","EBND","EWY","RGTZ","NUGT","LUNL","HUT","GDXJ","FEMB","RCAT","VOYX","PFFR","ITB","VOYG","HUTG","SOXL","VYGR","XHB","NLR","LUNR","SCO","UYM","ENPX","ENPH","PLTZ","PLTR","RGTI","RCAX","UWM","GDX","GDXD","CARD","EWZ","EDC","GLL","PFXF","EMLC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1154333570","title":"Voyager Therapeutics Inc 2025年末现金储备达2.02亿美元 预计资金可支撑至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1154333570","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154333570?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:06","pubTimestamp":1773086787,"startTime":"0","endTime":"0","summary":"基因疗法先驱Voyager Therapeutics Inc（股票代码：VYGR）宣布，公司在2025财年末持有强劲的现金及现金等价物，总额达到2.02亿美元。这一坚实的财务基础为公司未来的研发活动提供了充足保障。\n基于当前的资金状况和审慎的财务规划，管理层预计，现有的现金储备足以支持公司的运营开支和战略项目推进，资金跑道（Runway）将延续至2028年。这一预期为Voyager Therapeutics在神经科学领域持续开发创新疗法奠定了稳定的财务基石。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYGR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517921336","title":"Voyager Therapeutics, Inc.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517921336?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:00","pubTimestamp":1741208406,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日05时00分，Voyager Therapeutics, Inc.股票出现波动，股价大幅拉升5.05%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.91%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为1002.54%、325.26%、322.89%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为974.63%、82.59%、54.27%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050007a261331b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050007a261331b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VYGR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516655100","title":"HC Wainwright & Co.：重申Voyager Therapeutics(VYGR.US)评级，由买入调整至买入评级, 目标价由30.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655100","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516655100?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:41","pubTimestamp":1741020070,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Voyager Therapeutics(VYGR.US)评级，由买入调整至买入评级, 目标价由30.00美元调整至30.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04004148498636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169082","title":"Voyager Therapeutics, Inc.盘中异动 早盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512169082?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:25","pubTimestamp":1739892310,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时25分，Voyager Therapeutics, Inc.股票出现异动，股价急速上涨5.03%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为360.21%、153.06%、136.45%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为148.75%、73.77%、51.40%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232510abd3bb91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232510abd3bb91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VYGR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380168","title":"Voyager Therapeutics, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380168?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284280,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Voyager Therapeutics, Inc.股票出现异动，股价快速下挫5.17%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1895.44%、510.17%、171.76%，振幅较大的相关个股有Akari Therapeutics Plc、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为16.07%、14.11%、11.28%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223120abcb05ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223120abcb05ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506303236","title":"Voyager Therapeutics, Inc.盘中异动 急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506303236?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:48","pubTimestamp":1737989282,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时48分，Voyager Therapeutics, Inc.股票出现异动，股价大幅拉升5.16%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Pmgc Holdings Inc.较为活跃，换手率分别为1069.53%、148.37%、63.66%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为85.35%、65.16%、53.97%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722480296123c41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722480296123c41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503164207","title":"Voyager Therapeutics, Inc.盘中异动 股价大涨5.94%报5.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503164207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503164207?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951524,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Voyager Therapeutics, Inc.股票出现波动，股价快速拉升5.94%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为184.95%、52.33%、35.37%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.、Viracta Therapeutics, Inc.，振幅分别为12.00%、10.72%、9.48%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223204a222fdf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223204a222fdf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503585180","title":"Voyager Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503585180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503585180?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:38","pubTimestamp":1736779124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时38分，Voyager Therapeutics, Inc.股票出现异动，股价急速下跌5.08%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3789.19%、2232.13%、395.24%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、67.46%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223844aba932fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223844aba932fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494633347","title":"Voyager Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494633347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494633347?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:19","pubTimestamp":1735319957,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时19分，Voyager Therapeutics, Inc.股票出现异动，股价快速下跌5.08%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Vor Biopharma Inc.、Abpro Holdings, Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Neuphoria Therapeutics Inc.较为活跃，换手率分别为119.52%、57.63%、51.53%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Galectin Therapeutics Inc.、Abpro Holdings, Inc，振幅分别为147.50%、65.39%、62.45%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011917ab95131c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011917ab95131c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489234809","title":"Voyager Therapeutics, Inc.盘中异动 早盘股价大涨5.13%报6.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489234809?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:14","pubTimestamp":1733498073,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时14分，Voyager Therapeutics, Inc.股票出现波动，股价急速拉升5.13%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Adc Therapeutics Sa、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为49.05%、36.97%、24.35%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cardio Diagnostics Holdings Inc.，振幅分别为27.68%、26.58%、24.33%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623143398e5e3c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623143398e5e3c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488941879","title":"Voyager Therapeutics, Inc.盘中异动 早盘快速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488941879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488941879?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:09","pubTimestamp":1733238547,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时09分，Voyager Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为138.22%、96.43%、87.64%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Exicure, Inc.，振幅分别为51.13%、48.91%、35.65%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323090798e51dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323090798e51dcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYGR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488367759","title":"Voyager Therapeutics, Inc.盘中异动 早盘快速上涨7.25%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488367759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488367759?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:34","pubTimestamp":1733150044,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时34分，Voyager Therapeutics, Inc.股票出现波动，股价大幅拉升7.25%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为726.15%、691.72%、204.23%，振幅较大的相关个股有Senti Biosciences, Inc.、Cabaletta Bio, Inc.、Purple Biotech Ltd，振幅分别为49.54%、20.68%、20.27%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223404a2669a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223404a2669a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYGR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485127294","title":"Voyager Therapeutics, Inc.盘中异动 股价大涨5.30%报5.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485127294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485127294?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:42","pubTimestamp":1732297353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时42分，Voyager Therapeutics, Inc.股票出现波动，股价快速拉升5.30%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Candel Therapeutics, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1855.81%、151.27%、94.19%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为81.82%、75.33%、72.75%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014234abd7de8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014234abd7de8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484146641","title":"Voyager Therapeutics, Inc.盘中异动 股价大涨5.12%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484146641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484146641?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:39","pubTimestamp":1732117176,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时39分，Voyager Therapeutics, Inc.股票出现波动，股价快速拉升5.12%。Voyager Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Forte Biosciences, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1105.60%、669.97%、233.25%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为183.66%、121.32%、73.14%。Voyager Therapeutics, Inc.公司简介：Voyager Therapeutics Inc是一家基因治疗公司，专注于为患有严重神经系统疾病的患者开发改变生活的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120233936971a7b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120233936971a7b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VYGR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.voyagertherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0231},{"period":"1month","weight":0.18},{"period":"3month","weight":-0.0221},{"period":"6month","weight":-0.0923},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":-0.0992}],"compareEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.0099},{"period":"3month","weight":0.0107},{"period":"6month","weight":0.138},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1221}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Voyager Therapeutics, Inc.于2013年6月根据特拉华州法律成立。该公司是一家致力于突破基因治疗和神经学障碍的生物技术公司。该公司的基因治疗平台使他们能够设计、优化、制造和提供基于AAV的基因疗法，他们认为这些疗法有可能安全地提供持久的疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.004281},{"month":2,"riseRate":0.545455,"avgChangeRate":0.057874},{"month":3,"riseRate":0.454545,"avgChangeRate":0.037898},{"month":4,"riseRate":0.454545,"avgChangeRate":0.014405},{"month":5,"riseRate":0.636364,"avgChangeRate":0.040925},{"month":6,"riseRate":0.454545,"avgChangeRate":0.000781},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.029504},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.006182},{"month":9,"riseRate":0.272727,"avgChangeRate":0.067333},{"month":10,"riseRate":0.3,"avgChangeRate":-0.010359},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07862},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.036226}],"exchange":"NASDAQ","name":"Voyager Therapeutics Inc","nameEN":"Voyager Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Voyager Therapeutics Inc(VYGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Voyager Therapeutics Inc(VYGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Voyager Therapeutics Inc,VYGR,Voyager Therapeutics Inc股票,Voyager Therapeutics Inc股票老虎,Voyager Therapeutics Inc股票老虎国际,Voyager Therapeutics Inc行情,Voyager Therapeutics Inc股票行情,Voyager Therapeutics Inc股价,Voyager Therapeutics Inc股市,Voyager Therapeutics Inc股票价格,Voyager Therapeutics Inc股票交易,Voyager Therapeutics Inc股票购买,Voyager Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Voyager Therapeutics Inc(VYGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Voyager Therapeutics Inc(VYGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}